| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 05/29/2007 | US7223576 Expression vector which utilizes site specific recombinases as insertion tools during in vivo and/or in vitro gene transfer |
| 05/29/2007 | US7223575 Zymomonas pentose-sugar fermenting strains and uses thereof |
| 05/29/2007 | US7223572 Methylophilus methylotrophus having enhanced dihydrodipicolinate synthase and/or aspartokinase activity for L-amino acid production |
| 05/29/2007 | US7223569 For increasing yield, disease resistance, insect resistance, herbicide tolerance, drought tolerance, and salt tolerance |
| 05/29/2007 | US7223566 Generating transgenic bacteria coding/expressing eschrichia thioredoxin fusion protein for use as diagnostic marker in heterologous gene expression; bioreactors |
| 05/29/2007 | US7223565 for drug screening interleukins; expression in bacteria, yeast, plant, insect, and animal cells; genetic engineering |
| 05/29/2007 | US7223564 Four-helical bundle protein zsig81 |
| 05/29/2007 | US7223563 Nucleic acids; diagnosing and treating hypophosphatemic disorders; diagnosing tumor induced osteomalacia |
| 05/29/2007 | US7223562 Nucleic acid and amino acid sequences of FP-1 protein expressed in follicular papilla of hair follicle; antibodies; transformation, genetic engineering |
| 05/29/2007 | US7223561 Culturing yeast transformed with albumin-encoding nucleotide sequence in a fermentation medium; gene expression, separation, conditioning, adding sodium octanoate; cationic exchange chromatography, elution, ultrafiltration, sterilization, diafiltration, filling vessel |
| 05/29/2007 | US7223560 DNA virus for use as transfection and protein expression tool in genetic engineering; bioreactors for screening protein folding activities; diagnosis and treatment of polypeptide misfolding disorders |
| 05/29/2007 | US7223559 Plasmids for chromosomal recombination of Escherichia coli |
| 05/29/2007 | US7223558 Fibronectins; drug screening; treating cardiovascular/nervous system disorders |
| 05/29/2007 | US7223557 Polynucleotide encoding a TRP channel family member, TRP-PLIK2 |
| 05/29/2007 | US7223556 Targeted proteolysis by recruitment to ubiquitin protein ligases |
| 05/29/2007 | US7223551 Comprises nucleotide sequences coding g-protein coupled receptors for identifying modulators of taste enhancement; food processing and drug design; screening tastants |
| 05/29/2007 | US7223550 Biosensor for defecting chemical agents |
| 05/29/2007 | US7223548 Cotransfecting cells with nucleic acid; dividing into portions to be drug screened and unscreened for regulators of expression of human aromatase gene; determining level of gene expression of reporter gene; breast cancer |
| 05/29/2007 | US7223547 for drug screening using genomic expression libraries; solid phase synthesis; kits; genetic engineering |
| 05/29/2007 | US7223545 Using immobilized oligonucleotides as tools in synthesis, selection, amplification and evolution of non-natural molecules based on nucleic acid templates |
| 05/29/2007 | US7223543 Conjugated linoleic acid isomerase and a process for the production of conjugated linoleic acid |
| 05/29/2007 | US7223542 Diagnosing cancer via determining concentration of marker polypeptides; genetic vaccines; antiproliferative/antitumor agents |
| 05/29/2007 | US7223539 Method and kits for preparing multicomponent nucleic acid constructs |
| 05/29/2007 | US7223538 Gene expression layouts; immobilization on support; hybrid detector |
| 05/29/2007 | US7223537 Particle for use in detection of protein binding positions; antitumor agents |
| 05/29/2007 | US7223536 Detecting single nucleotide polymorphisms during amplification of the target sequence based upon the relative inefficiency of primer extension by DNA polymerases when there are mismatches at the 3' end of a hybridized primer |
| 05/29/2007 | US7223412 Staphylococcal enterotoxin SEC-SER, expression vector and host cell, production method thereof, and manufacturing method of vaccine |
| 05/29/2007 | US7223411 Administering a mutated herpesvirus having a mutation in genes encoding a protein essential for viral genome replication to render the herpesvirus replication defective; effecting an antibody subclass shift of IgG2a/IgG upon in vivo administration |
| 05/29/2007 | US7223398 Population of conjugate molecules of an allergen and a polynucleotide comprising an immunostimulatory sequence; polynucleotide conjugated, or attached, to antigens |
| 05/29/2007 | US7223395 Blocking leukocyte emigration and inflammation by interfering with CD99/HEC2 |
| 05/29/2007 | US7223394 Human antibodies that bind human TNFα |
| 05/29/2007 | US7223393 Monoclonal antibodies for use in the prevention and treatment of cell proliferative and skin disorders; immunotherapy; antitumor agents |
| 05/29/2007 | US7223392 Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as therapeutics |
| 05/29/2007 | US7223389 Compositions and methods for treatment of cancer |
| 05/29/2007 | US7223388 Reoviridae virus is conjugated to a hydroxylated hydrocarbon or a polycationic polymer to reduce the clearance and immunogenicity; antiproliferative disorders |
| 05/29/2007 | US7223330 Biosensor, biosensor array and method for detecting macromolecular biopolymers with a biosensor |
| 05/29/2007 | CA2389990C Compositions and methods for modulation of plant cell division |
| 05/29/2007 | CA2386642C Electrochemiluminescence helicase assay |
| 05/29/2007 | CA2341685C Secreted renilla luciferase |
| 05/29/2007 | CA2268758C Immunogenic detoxified mutant e. coli lt-a toxin |
| 05/29/2007 | CA2262476C Viral vectors and their uses |
| 05/29/2007 | CA2236998C Tissue-specific and target rna-specific ribozymes |
| 05/29/2007 | CA2206265C Process for reducing rna concentration in a mixture of biological material using diatomaceous earth |
| 05/29/2007 | CA2120265C Phytate hydrolysis and enzyme composition for hydrolizing phytate |
| 05/29/2007 | CA2082042C Production of plants resistant to attacks of sclerotinia sclerotiorum by introducing a gene coding for an oxalate oxidase |
| 05/24/2007 | WO2007059473A2 Methods for the production and purification of adenoviral vectors |
| 05/24/2007 | WO2007059366A2 Reagents and methods for modulating gene expression related to hypertension |
| 05/24/2007 | WO2007059256A2 Pro-apoptotic bacteria and compositions for delivery and expression of antigens |
| 05/24/2007 | WO2007059092A1 Methods and compositions for reducing the expression of a polynucleotide of interest |
| 05/24/2007 | WO2007059077A2 Compositions and methods for altering alpha- and beta-tocotrienol content |
| 05/24/2007 | WO2007058992A2 Mutations and polymorphisms of hdac6 |
| 05/24/2007 | WO2007058991A2 Mutations and polymorphisms of c-abl |
| 05/24/2007 | WO2007058894A2 Splice switching oligomers for tnf superfamily receptors and their use in treatment of disease |
| 05/24/2007 | WO2007058833A2 Dof (dna binding with one finger) sequences and methods of use |
| 05/24/2007 | WO2007058823A2 Anti-egfr antibodies |
| 05/24/2007 | WO2007058807A1 Screening method for dnak inhibitors |
| 05/24/2007 | WO2007058625A1 Toxin-antitoxin system and applications thereof |
| 05/24/2007 | WO2007058527A2 Inducible expression systems |
| 05/24/2007 | WO2007058407A1 Translational elongation factor promoter from pichia pastoris and method for producing recombinant protein using the same |
| 05/24/2007 | WO2007058381A1 Novel highly functional enzyme having modified substrate-specificity |
| 05/24/2007 | WO2007058376A1 Method for efficient synthesis of protein having labeled n-terminal amino acid residue |
| 05/24/2007 | WO2007058360A1 Therapeutic agent for skin or skin repair-promoting agent comprising des-acylghrelin or derivative thereof as active ingredient |
| 05/24/2007 | WO2007058359A1 THERAPEUTIC AGENT FOR SKIN OR SKIN REPAIR-PROMOTING AGENT COMPRISING GHRELIN, DERIVATIVE THEREOF OR SUBSTANCE CAPABLE OF ACTING ON GHS-R1a AS ACTIVE INGREDIENT |
| 05/24/2007 | WO2007058326A1 Method for detecting target nucleic acid with specific base sequence and set of nucleic acids for detection |
| 05/24/2007 | WO2007058323A1 Method for production of nucleic acid homopolymer-bound functional nucleic acid medicine |
| 05/24/2007 | WO2007058267A1 Novel protein and gene encoding the protein |
| 05/24/2007 | WO2007058252A1 Process for producing chondroitin |
| 05/24/2007 | WO2007058235A1 Fusion protein and use thereof for pharmaceutical purposes |
| 05/24/2007 | WO2007058140A1 Luciferase gene optimized for use in imaging of intracellular luminescence |
| 05/24/2007 | WO2007058086A1 Ketose 3-epimerase, process for production thereof, and use thereof |
| 05/24/2007 | WO2007058077A1 Gene test method, microreactor for gene test and gene test system |
| 05/24/2007 | WO2007058021A1 Animal model and method for producing the same |
| 05/24/2007 | WO2007057989A1 Method of liquid droplet formation and transport, apparatus therefor and particle manipulating apparatus |
| 05/24/2007 | WO2007057949A1 Method of producing heterodimer derivative of protein phosphatase type 2a enzyme |
| 05/24/2007 | WO2007057682A1 A method for in vitro molecular evolution of protein function |
| 05/24/2007 | WO2007057670A1 Nidogen/snep-iike molecule |
| 05/24/2007 | WO2007057652A1 Method of target enrichment |
| 05/24/2007 | WO2007057617A1 Lectin-defencin chimeric protein |
| 05/24/2007 | WO2007057418A1 Polypeptides having endoglucanase activity and polynucleotides encoding same |
| 05/24/2007 | WO2007057402A1 Emp4 gene |
| 05/24/2007 | WO2007057368A1 Viral vector, use thereof for therapy of liver cell carcinomas and pharmaceutical composition comprising the vector |
| 05/24/2007 | WO2007057062A1 Human bocavirus and methods of diagnosis and treatment |
| 05/24/2007 | WO2007056931A1 Use of glucose isomerase mutants |
| 05/24/2007 | WO2007056930A1 Glucose isomerase mutants, the use thereof and the dnas encoding the same |
| 05/24/2007 | WO2007056867A1 Modified pore-forming protein toxins and use thereof |
| 05/24/2007 | WO2007056861A1 Sirna silencing of influenza virus gene expression |
| 05/24/2007 | WO2007056858A1 Anti-alpha2 integrin antibodies and their uses |
| 05/24/2007 | WO2007056848A1 Use of bacteriocins for promoting plant growth and disease resistance |
| 05/24/2007 | WO2007056847A1 Stabilizing formulations for recombinant viruses |
| 05/24/2007 | WO2007056829A1 Multitargeting interfering rnas having two active strands and methods for their design and use |
| 05/24/2007 | WO2007056826A1 Multitargeting interfering rnas and methods of their use and design |
| 05/24/2007 | WO2007056825A1 Method and probes for identifying a nucleotide sequence |
| 05/24/2007 | WO2007056823A1 Feedstuffs for aquaculture comprising stearidonic acid feedstuffs for aquaculture |
| 05/24/2007 | WO2007039699A3 Proteinaceous substrate for the detection of calpain-3 activity |
| 05/24/2007 | WO2007037509A9 Nucleic acid extraction method |
| 05/24/2007 | WO2007037133A9 Method for evaluation of compound capable of acting on plk3 |
| 05/24/2007 | WO2007032837A3 Method for in vitro recombination |
| 05/24/2007 | WO2007029270A3 Abiotic stress tolerant gene from avicennia marina encoding a protein |
| 05/24/2007 | WO2007027777A3 Nucleotide sequences encoding insecticidal proteins |
| 05/24/2007 | WO2007027105A3 Compositions and methods for modulating pigment production in plants |